Occudo Quantitative Strategies LP Buys 9,595 Shares of The Pennant Group, Inc. (NASDAQ:PNTG)

Occudo Quantitative Strategies LP boosted its stake in The Pennant Group, Inc. (NASDAQ:PNTG - Free Report) by 150.6% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 15,966 shares of the company's stock after buying an additional 9,595 shares during the period. Occudo Quantitative Strategies LP's holdings in The Pennant Group were worth $423,000 at the end of the most recent quarter.

Several other large investors have also recently bought and sold shares of PNTG. Van Berkom & Associates Inc. boosted its holdings in shares of The Pennant Group by 2,635.6% in the fourth quarter. Van Berkom & Associates Inc. now owns 2,198,216 shares of the company's stock valued at $58,297,000 after acquiring an additional 2,117,859 shares in the last quarter. FMR LLC boosted its stake in The Pennant Group by 54.5% during the 4th quarter. FMR LLC now owns 3,906,327 shares of the company's stock valued at $103,596,000 after purchasing an additional 1,377,815 shares in the last quarter. Vanguard Group Inc. boosted its stake in The Pennant Group by 11.0% during the 4th quarter. Vanguard Group Inc. now owns 2,261,564 shares of the company's stock valued at $59,977,000 after purchasing an additional 223,919 shares in the last quarter. Millennium Management LLC increased its position in shares of The Pennant Group by 1,274.9% during the 4th quarter. Millennium Management LLC now owns 181,767 shares of the company's stock valued at $4,820,000 after purchasing an additional 168,547 shares during the period. Finally, Ranger Investment Management L.P. raised its stake in shares of The Pennant Group by 147.3% in the 4th quarter. Ranger Investment Management L.P. now owns 195,210 shares of the company's stock worth $5,177,000 after buying an additional 116,285 shares in the last quarter. Institutional investors and hedge funds own 85.88% of the company's stock.

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on the company. Stephens reaffirmed an "overweight" rating and set a $38.00 target price on shares of The Pennant Group in a report on Wednesday, April 2nd. Truist Financial raised their price objective on The Pennant Group from $28.00 to $32.00 and gave the stock a "hold" rating in a research note on Monday, May 12th. Two equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average price target of $35.60.

The Pennant Group Stock Down 0.8%

Shares of NASDAQ PNTG traded down $0.25 during trading hours on Wednesday, hitting $29.19. The stock had a trading volume of 23,762 shares, compared to its average volume of 223,727. The company has a market capitalization of $1.01 billion, a P/E ratio of 42.92, a P/E/G ratio of 2.24 and a beta of 1.56. The firm's 50-day moving average price is $25.97 and its two-hundred day moving average price is $27.19. The company has a debt-to-equity ratio of 0.58, a quick ratio of 1.12 and a current ratio of 1.12. The Pennant Group, Inc. has a 52 week low of $21.18 and a 52 week high of $37.13.

The Pennant Group Company Profile

The Pennant Group, Inc provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.